The Improved Experience You’ve Been Waiting For! Discover the refreshed menu, enjoy the custom dashboard, and make use of the powerful stock screener to enhance your investment approach. Explore Now

BIOG:LSE

1,060.00 -2.00 -0.188324
Icon

(BIOG:LSE) Stock Analysis and Price Targets

| Asset Management | LSE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

1,060.00

-2.00 (-0.19)%

0.34B

0.13M

N/A

N/A
Icon

BIOG:LSE

| LSE
1,060.00
0.00 0
Take a Tour
Target Discuss Watchlist
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

0.34B

N/A

1,060.00

(BIOG:LSE) Stock Forecast

N/A

Based on the stock forecast from 0 analysts, the average analyst target price for is not available over the next 12 months. ’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of is Very Bearish, which is based on 0 positive signals and 2 negative signals. At the last closing, ’s stock price was USD 1,060.00. ’s stock price has changed by +3.11% over the past week, +8.05% over the past month and +33.17% over the last year.

No recent analyst target price found for
No recent average analyst rating found for

Company Overview

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector...Read More

https://www.biotechgt.com/index.php/biog/home/over

601 Lexington Avenue, New York, NY, United States, 10022

0

March

GBX

UK

Adjusted Closing Price for (BIOG:LSE)

Unadjusted Closing Price for (BIOG:LSE)

Share Trading Volume for Shares

Compare Performance of Shares

Symbol Capital Gain Dividend Return Total Return

Technical Indicators for BIOG:LSE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To (Sector: Asset Management )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
FP:LSE
0.00 (0.00%) 264.18B 2.94 N/A

ETFs Containing BIOG

Symbol Name BIOG's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About (BIOG:LSE) Stock

Stock Target Advisor's fundamental analysis for 's stock is Very Bearish.

Unfortunately we do not have enough data on BIOG:LSE's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BIOG:LSE's stock to indicate what its average analyst target is.

BIOG:LSE stock's Price/Earning ratio is 4.99. Based on this BIOG:LSE may be undervalued for its sector.

The last closing price of BIOG:LSE's stock was 1,060.00.

The most recent market capitalization for BIOG:LSE is 0.34B.

Unfortunately we do not have enough analyst data on BIOG:LSE's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains 's stock.

As per our most recent records has 0 Employees.

's registered address is 601 Lexington Avenue, New York, NY, United States, 10022. You can get more information about it from 's website at https://www.biotechgt.com/index.php/biog/home/over.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Stock Target Advisor

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like